225 related articles for article (PubMed ID: 33609747)
1. MITOCHONDRIA: Succinate dehydrogenase subunit B-associated phaeochromocytoma and paraganglioma.
Dona M; Neijman K; Timmers HJLM
Int J Biochem Cell Biol; 2021 May; 134():105949. PubMed ID: 33609747
[TBL] [Abstract][Full Text] [Related]
2. SDH-related pheochromocytoma and paraganglioma.
Kantorovich V; King KS; Pacak K
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):415-24. PubMed ID: 20833333
[TBL] [Abstract][Full Text] [Related]
3. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional consequences of succinate dehydrogenase subunit B mutations.
Kim E; Rath EM; Tsang VH; Duff AP; Robinson BG; Church WB; Benn DE; Dwight T; Clifton-Bligh RJ
Endocr Relat Cancer; 2015 Jun; 22(3):387-97. PubMed ID: 25972245
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of the oncometabolite succinate in SDHx-mutation carriers.
Eijkelenkamp K; Osinga TE; Links TP; van der Horst-Schrivers ANA
Clin Genet; 2020 Jan; 97(1):39-53. PubMed ID: 30977114
[TBL] [Abstract][Full Text] [Related]
6. A conditional mouse mutant in the tumor suppressor SdhD gene unveils a link between p21(WAF1/Cip1) induction and mitochondrial dysfunction.
Millán-Uclés A; Díaz-Castro B; García-Flores P; Báez A; Pérez-Simón JA; López-Barneo J; Piruat JI
PLoS One; 2014; 9(1):e85528. PubMed ID: 24465590
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of tumorigenesis caused by succinate dehydrogenase defect.
Moosavi B; Zhu XL; Yang WC; Yang GF
Eur J Cell Biol; 2020 Jan; 99(1):151057. PubMed ID: 31810635
[TBL] [Abstract][Full Text] [Related]
8. Loss of SDHB Elevates Catecholamine Synthesis and Secretion Depending on ROS Production and HIF Stabilization.
Saito Y; Ishii KA; Aita Y; Ikeda T; Kawakami Y; Shimano H; Hara H; Takekoshi K
Neurochem Res; 2016 Apr; 41(4):696-706. PubMed ID: 26620190
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
[TBL] [Abstract][Full Text] [Related]
10. An Update on the Histology of Pheochromocytomas: How Does it Relate to Genetics?
Oudijk L; Gaal J; Koopman K; de Krijger RR
Horm Metab Res; 2019 Jul; 51(7):403-413. PubMed ID: 30142639
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M
Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
[TBL] [Abstract][Full Text] [Related]
13. Modeling succinate dehydrogenase loss disorders in C. elegans through effects on hypoxia-inducible factor.
Braun MM; Damjanac T; Zhang Y; Chen C; Hu J; Maher LJ
PLoS One; 2019; 14(12):e0227033. PubMed ID: 31887185
[TBL] [Abstract][Full Text] [Related]
14. Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function.
Rapizzi E; Fucci R; Giannoni E; Canu L; Richter S; Cirri P; Mannelli M
Endocr Relat Cancer; 2015 Jun; 22(3):409-17. PubMed ID: 25808177
[TBL] [Abstract][Full Text] [Related]
15. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.
Richter S; Peitzsch M; Rapizzi E; Lenders JW; Qin N; de Cubas AA; Schiavi F; Rao JU; Beuschlein F; Quinkler M; Timmers HJ; Opocher G; Mannelli M; Pacak K; Robledo M; Eisenhofer G
J Clin Endocrinol Metab; 2014 Oct; 99(10):3903-11. PubMed ID: 25014000
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas.
Cassol CA; Winer D; Liu W; Guo M; Ezzat S; Asa SL
Mod Pathol; 2014 Aug; 27(8):1050-62. PubMed ID: 24390213
[TBL] [Abstract][Full Text] [Related]
17. Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.
Vicha A; Taieb D; Pacak K
Endocr Relat Cancer; 2014 Jun; 21(3):R261-77. PubMed ID: 24500761
[TBL] [Abstract][Full Text] [Related]
18. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.
Kimura N; Takayanagi R; Takizawa N; Itagaki E; Katabami T; Kakoi N; Rakugi H; Ikeda Y; Tanabe A; Nigawara T; Ito S; Kimura I; Naruse M;
Endocr Relat Cancer; 2014 Jun; 21(3):405-14. PubMed ID: 24521857
[TBL] [Abstract][Full Text] [Related]
19. Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency.
Favier J; Brière JJ; Strompf L; Amar L; Filali M; Jeunemaitre X; Rustin P; Gimenez-Roqueplo AP;
Horm Res; 2005; 63(4):171-9. PubMed ID: 15795514
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical Staining for SOX10 and SDHB in SDH-Deficient Paragangliomas Indicates that Sustentacular Cells Are Not Neoplastic.
Powers JF; Tischler AS
Endocr Pathol; 2020 Sep; 31(3):307-309. PubMed ID: 32562155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
